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TssA is a core subunit of the type VI secretion system, which is a major player
in interspecies competition in Gram-negative bacteria. Previous studies on
enteroaggregative Escherichia coli TssA suggested that it is comprised of three
putative domains: a conserved N-terminal domain, a middle domain and a ring-
forming C-terminal domain. X-ray studies of the latter two domains have
identified their respective structures. Here, the results of the expression and
purification of full-length and domain constructs of TssA from Aeromonas
hydrophila are reported, resulting in diffraction-quality crystals for the middle
domain (Nt2) and a construct including the middle and C-terminal domains
(Nt2-CTD).
1. Introduction
The type VI secretion system (T6SS) is a multiprotein
complex found in Gram-negative bacteria that is involved in
the delivery of various effector proteins into target cells. It is
thought to be evolutionarily related to the contractile tail
assembly of bacteriophages (for example T4) and to R-type
pyocins, which all share a similar contraction mechanism
(Leiman et al., 2009; Basler et al., 2012; Ge et al., 2015). These
nanomachines utilize a platform known as the baseplate, onto
which a tube, surrounded by a contractile sheath, is poly-
merized. The inner tube is capped at the baseplate end with
proteins that provide a tapered end, which facilitates the
penetration of target cells upon contraction of the sheath
against the baseplate (Leiman et al., 2009; Shneider et al., 2013;
Ge et al., 2015). The T6SS is comprised of multiple copies of 13
core subunits, and a single PAAR tip protein, that collectively
can be categorized into two major components. The first is the
membrane complex, consisting of ten copies each of TssJ, TssL
and TssM. Together, these form a transmembrane assembly
which acts as an ‘anchor’ for the other component, the
‘injection machinery’. In addition, it allows the passage of the
contractile tube and the associated effector proteins out of the
bacterium (Zheng & Leung, 2007; Boyer et al., 2009; Durand et
al., 2015; Cianfanelli et al., 2016). The injection machinery
consists of two subcomplexes. One of these contains the tube,
which is comprised of stacked hexamers of TssD (Hcp) and is
capped by a trimer of TssI (VgrG) and a single PAAR subunit.
The tube is surrounded by polymerized heterodimers of
TssBC, arranged in a six-start helix, that form the contractile
sheath (Basler et al., 2012; Shneider et al., 2013; Brunet et al.,
ISSN 2053-230X
2014; Kube et al., 2014; Wang et al., 2017). The tube and sheath
are assembled on the second subcomplex, the baseplate, which
contains TssE, TssF, TssG and TssK. During contraction of the
sheath against the baseplate, the inner tube and associated
effector proteins are driven through an opening in the centre
of the baseplate (Pukatzki et al., 2007; Brunet et al., 2015;
Taylor et al., 2016). Post-construction, the sheath is then
recycled by the AAA+ ATPase TssH (ClpV; Bo¨nemann et al.,
2009; Basler et al., 2012).
Until recently, very little was known regarding the role and
location of the TssA subunit within the T6SS complex. It has
been shown that all TssAs comprise a conserved N-terminal
region containing a domain of unknown function termed
ImpA_N (Pfam PF0681224; Finn et al., 2016) in addition to a
divergent C-terminal region (Shalom et al., 2007; Zoued et al.,
2017). Recent fluorescence microscopy and cryo-EM struc-
tural studies on enteroaggregative Escherichia coli (EAEC)
and Vibrio cholerae T6SS, respectively, have shown that TssA
is located and maintained at the baseplate distal end of the
growing TssBCD complex during tube and sheath poly-
merization (Zoued et al., 2016; Nazarov et al., 2018).
Furthermore, proteolytic and structural studies of domains
from EAEC TssA (Ec042_4540; Ec-TssA) have identified a
putative three-domain organization corresponding to an
N-terminal domain, a middle domain and a C-terminal domain,
and have provided X-ray structures for the latter two. This
revealed that the C-terminal domain is organized into a six-
pointed star consisting of 12 subunits with D6 symmetry
(Zoued et al., 2016).
We have observed that some TssA homologues are 40
amino acids shorter at the C-terminus compared with Ec-
TssA. This prompted an investigation into one such TssA
subunit, AHA1844, that is present in Aeromonas hydrophila
ATCC 7966. In this paper, we report the generation of suitable
constructs for the crystallization of A. hydrophila TssA (Ah-
TssA) and its constituent domains (N-terminal domain, Nt1;
middle domain, Nt2; C-terminal domain, CTD). Furthermore,
we present the first crystallization trials and X-ray diffraction
data for proteins derived from constructs of both the Ah-TssA
Nt2 and Nt2-CTD domains as initial steps to determining the
structures of these domains and their relationship to EAEC
TssA.
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Figure 1
Putative domain boundaries of Ah-TssA and Ec-TssA. Proteolytic and structural studies of Ec-TssA identified putative domain boundaries for Nt1, Nt2
and CTD (Zoued et al., 2016). This information was used along with a sequence alignment between Ah-TssA and Ec-TssA to design suitable Ah-TssA
domain constructs for crystallization. The key indicates the colour assigned to each putative domain.
2. Materials and methods
2.1. Macromolecule production
Domain boundaries for Nt1, Nt2 and CTD were defined
using an amino-acid sequence alignment of Ec-TssA and Ah-
TssA (Fig. 1). DNAs encoding Ah-TssA or Ah-TssA domains
(UniProt A0KJC7) were amplified from A. hydrophila ATCC
7966 (Seshadri et al., 2006) by the polymerase chain reaction
(PCR) utilizing the primer pairs described in Table 1. The
products were then ligated into the pACYCDuet-1 expression
vector (Novagen) downstream of the first T7 promoter using
compatible restriction sites. The recombinant expression
plasmids containing tssa DNA were transformed into E. coli
strain JM83 (Yanisch-Perron et al., 1985), verified by nucleo-
tide sequencing and then transformed into E. coli BL21(DE3)
cells (Novagen; Studier & Moffatt, 1986) for protein over-
production (Hanahan, 1983).
Ah-TssA constructs representing the full-length protein,
the three identified domains (Nt1, Nt2 and CTD) and a
combination of two of them (Nt2-CTD) were grown in 2 l BHI
broth (Oxoid) at 37C with 25 mg ml1 chloramphenicol. Once
the cultures had reached an OD600 of 0.5–0.7, IPTG was added
to a final concentration of 1 mM (0.1 mM for His6.Ah-TssA
Nt2) for the induction of the T7 promoter present within each
expression vector (Table 1). Cultures were incubated for a
further 2–3 h at 37C (30C was used to induce the synthesis of
His6.Ah-TssA, His6.Ah-TssA Nt1 and His6.Ah-TssA Nt2)
before the cells were harvested. The harvested cells were
resuspended in 50 mM Tris–HCl pH 8.0 containing 2 mM
EDTA, 200 mM NaCl, 10% glycerol (5 ml per gram of cell
paste), treated with lysozyme (0.2 mg ml1) for 30 min at 4C
followed by sodium deoxycholate (0.5 mg ml1) and PMSF
(25 mg ml1) for a further 30 min, and lysed by sonication
[EDTA was omitted and imidazole (10 mM final concentra-
tion) was included if the protein was to be purified by nickel-
affinity chromatography, and the lysozyme and sodium
deoxycholate steps were omitted if the cell paste was frozen
before the sonication step]. The lysate was then cleared by
centrifugation for 30 min at 35 000g.
His-tagged proteins (i.e. all constructs except Ah-TssA
CTD) were applied onto a 5 ml HisTrap HP 5 ml column (GE
Healthcare Life Sciences) and eluted with a linear gradient of
imidazole (10–500 mM). His6.Ah-TssAwas further purified by
SEC (Superose 6 10/300 GL, GE Healthcare Life Sciences) in
50 mM Tris–HCl pH 8.0 containing 500 mM NaCl. The Ah-
TssA CTD lysate was first precipitated with 4M ammonium
sulfate and the pellet was subsequently resuspended in 50 mM
Tris–HCl pH 8.0 and applied onto an anion-exchange column
(Resource Q 6 ml, GE Healthcare Life Sciences) before being
eluted with a linear gradient of NaCl (0–500 mM). Ah-TssA
CTD was further purified by SEC (HiLoad Superdex 200
16/600, GE Healthcare Life Sciences) in 50 mM Tris–HCl pH
8.0 containing 500 mM NaCl. Protein purity was analysed by
SDS–PAGE and subsequent staining.
2.2. Crystallization
Crystallization trials were performed on all purified Ah-
TssA constructs using the protein concentration and protein
buffer compositions shown in Table 2. Initial screening was
carried out using a Matrix Hydra II Plus One crystallization
robot dispensing into 96-well MRC2 sitting-drop crystal-
lization trays, whereby a 1:1 ratio of precipitant:protein was
created generating 400 nl drops, which were allowed to equi-
librate through vapour diffusion at 290 K (280 K for Ah-TssA
Nt2-CTD). Commercially available sparse-matrix screens (pH
Clear, Morpheus, PACT, JCSG+, MPD and ProPlex) were
used to identify conditions that formed crystals. Successful
crystallization conditions for each construct, if applicable, can
be found in Table 2. Optimization of conditions was carried
out when required in 24-well trays with a reservoir volume of
500 ml and a drop size of 2 ml. A mercury derivative of the
His6.Ah-TssA Nt2 crystals was generated by the addition of
powdered ethylmercury phosphate (EMP; 20 mg) to a drop
containing crystals to provide a derivative.
2.3. Data collection and processing
Crystals were harvested in cryoloops (Hampton Research)
and immediately soaked in a solution consisting of mother
liquor with an additional 25%(v/v) ethylene glycol [supple-
mented with an additional 10%(v/v) glycerol for crystals of
His6.Ah-TssA Nt2] for about 10 s before being flash-cooled to
100 K in liquid nitrogen. Native data were collected for crys-
tals of His6.Ah-TssA Nt2 and His6.Ah-TssACTD-Nt2 on MX
beamlines I03 and I04 at Diamond Light Source, Oxford,
respectively. In addition, data for a mercury derivative of
crystals of His6.Ah-TssA Nt2 were collected on beamline I03.
Diffraction data were collected as shown in Table 3 and the
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Table 1
Primers and construct design.
Bold sequences indicate restriction sites.
Construct His6.Ah-TssA His6.Ah-TssA Nt1 His6.Ah-TssA Nt2 Ah-TssA CTD His6.Ah-TssA Nt2-CTD
Forward primer GCGCAGATCTAATGAGCT
ATCAACACCCCTG
GCGCAGATCTAATGAGCT
ATCAACACCCCTG
GCGCGGATCCAGGCGTCG
ACGTCGACAGTTC
GCGCGGATCCGAGTGCGG
GCATTGGCGAGGC
GCGCGGATCCAGGCGTCG
ACGTCGACAGTTC
Reverse primer GCGCAAGCTTTCATTTCG
ACAACGGCGCCG
GCGCGGTACCTTAGCTGG
AACTGTCGACGTCGACG
GCGCAAGCTTTTAAGCCT
CGCCAATGCCCGCACT
GCGCAAGCTTTCATTTCG
ACAACGGCGCCG
GCGCAAGCTTTCATTTCG
ACAACGGCGCCG
Cloning/expression
vector
pACYCDuet-1 pACYCDuet-1 pACYCDuet-1 pACYCDuet-1 pACYCDuet-1
Restriction sites BamHI and HindIII BamHI and KpnI BamHI and HindIII BamHI and HindIII BamHI and HindIII
Expression host E. coli BL21(DE3) E. coli BL21(DE3) E. coli BL21(DE3) E. coli BL21(DE3) E. coli BL21(DE3)
Amino acids His6.(1–478) (52.6 kDa) His6.(1–229) (26.0 kDa) His6.(223–387) (19.7 kDa) 381–478 (10.7 kDa) His6.(223–478) (29.8 kDa)
data were processed utilizing the xia2 software pipeline
(Winter, 2010; Winter & McAuley, 2011) with/without running
the optional XDS package (Kabsch, 2010) as indicated. All
details of data processing are shown in Table 3. The estimated
content of the asymmetric unit and the self-rotation function
were determined using the CCP4 suite (Winn et al., 2011).
3. Results and discussion
The full-length TssA construct, His6.Ah-TssA, and the four
different domain constructs were all successfully over-
produced and purified as described. The final protein yields
after purification were 14 mg for His6.Ah-TssA, 5.6 mg for
His6.Ah-TssA Nt1, 2.7 mg for His6.Ah-TssA Nt2, 7.2 mg for
Ah-TssA CTD and 16 mg for His6Ah-TssA Nt2-CTD.
Analysis by gel filtration indicates that His6.Ah-TssA Nt1 is
monomeric and that His6.Ah-TssA Nt2 is present as a dimer,
whereas gel filtration of His6.Ah-TssA, Ah-TssA CTD and
His6.Ah-TssA Nt2-CTD indicated approximate molecular
weights of 0.6, 0.2 and 0.4 MDa, respectively, indicating the
presence of larger complexes.
The full-length protein and the four domain constructs were
subjected to crystallization trials, and two (His6.Ah-TssA Nt2
and His6.Ah-TssA Nt2-CTD) produced crystals suitable for
data collection at Diamond Light Source, Oxford (Fig. 2).
SDS–PAGE analysis of the two purified protein constructs
(His6.Ah-TssA Nt2 and His6.Ah-TssA Nt2-CTD) indicated
initial purities of approximately >95% (Supplementary Fig.
S1). The crystals diffracted to 2.05 and 3.75 A˚ resolution,
respectively. The asymmetric unit of the His6.Ah-TssA Nt2
crystals is estimated to contain two molecules, with a probable
Matthews coefficient of 2.53 A˚3 Da1. Calculating the prob-
able Matthews coefficient for the data from the His6.Ah-TssA
Nt2-CTD crystals suggested an asymmetric unit containing
research communications
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Table 3
Data collection and processing.
Values in parentheses are for the outer shell.
Construct His6.Ah-TssA Nt2 His6.Ah-TssA Nt2 His6.Ah-TssA Nt2-CTD
Crystal Native EMP derivative Native
Diffraction source I03 I03 I04
Wavelength (A˚) 0.9763 1.0088 0.9795
Temperature (K) 100 100 100
Detector PILATUS 6M-F PILATUS 6M-F PILATUS 6M-F
Rotation range per image () 0.1 0.1 0.1
Total rotation range () 200 360 200
Exposure time per image (s) 0.05 0.05 0.1
Data-processing package xia2 -3dii xia2 -3dii DIALS
Space group P21 P21 P21
a, b, c (A˚) 46.0, 40.1, 101.0 46.1, 40.1, 100.8 73.0, 202.7, 137.7
, ,  () 90.0, 103.2, 90.0 90, 102.7, 90 90.0, 92.3, 90.0
Cell volume (A˚3) 181631 182001 2036168
Resolution range (A˚) 2.05 (2.10–2.05) 2.28 (2.34–2.28) 3.75 (3.85–3.75)
Rmeas 0.142 (1.315) 0.176 (1.488) 0.117 (0.950)
CC1/2 0.995 (0.574) 0.996 (0.532) 0.862 (0.757)
hI/(I)i 6.2 (1.2) 7.3 (1.0) 6.8 (1.5)
Completeness (%) 98.8 (99.2) 99.3 (95.1) 100.0 (100.0)
Multiplicity 3.6 (3.7) 6.4 (5.0) 3.7 (3.7)
Total reflections 81939 (6224) 107275 (5874) 153004 (11196)
Unique reflections 22646 (1700) 16664 (1183) 41019 (3066)
Overall B factor from Wilson plot (A˚2) 31 42 170
Anomalous completeness (%) — 98.9 (93.2) —
Anomalous multiplicity — 3.3 (2.6) —
Anomalous correlation — 0.217 (0.022) —
Anomalous slope — 1.105 —
Table 2
Crystallization.
N/A: constructs that did not crystallize.
Construct His6.Ah-TssA His6.Ah-TssA Nt1 His6.Ah-TssA Nt2 Ah-TssA CTD His6.Ah-TssA Nt2-CTD
Method Vapour diffusion Vapour diffusion Vapour diffusion Vapour diffusion Vapour diffusion
Plate type 96-well MRC2 96-well MRC2 24-well optimization tray 96-well MRC2 24-well optimization tray
Temperature (K) 290 290 290 290 280
Protein concentration
(mg ml1)
10 10 10 18 11
Buffer composition of
protein solution
50 mM Tris–HCl pH 7.5,
100 mM NaCl
50 mM Tris–HCl pH 8.0,
50 mM NaCl
10 mM Tris–HCl pH 8.0 10 mM Tris–HCl
pH 8.0
10 mM Tris–HCl pH 8.0
Composition of reservoir
solution
N/A N/A 0.04M potassium phosphate
monobasic, 16%(w/v) PEG
8000, 20%(v/v) glycerol
N/A 0.2M sodium acetate, 0.1M
sodium citrate pH 5.5,
10%(w/v) PEG 4000
between 10 and 18 subunits. Analysis of a self-rotation func-
tion based on all data for 4–16 A˚ resolution with a range of
integration radii gave no indication as to the symmetry of
His6.Ah-TssA Nt2-CTD within the asymmetric unit. Preli-
minary data to 2.3 A˚ resolution from the mercury-soaked
His6.Ah-TssA Nt2 crystals provided an initial map to which
the sequence could be fitted, indicating that the crystals were
of the Nt2 domain (Supplementary Fig. S2). Refinement of the
structure and attempts to collect data to higher resolution are
currently ongoing.
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Figure 2
Crystals of Ah-TssA domains. (a) His6.Ah-TssA Nt2 crystals grown in 0.04M potassium phosphate monobasic, 16%(w/v) PEG 8000, 20%(v/v) glycerol.
(b) His6.Ah-TssA Nt2-CTD crystals grown optimally in 0.2M sodium acetate, 0.1M sodium citrate pH 5.5, 10%(w/v) PEG 4000.
